1 in 5 Children and 1 in 10 Adults Has Eczema. Most Are Managing It but You Have the Key to Reverse It.

Eczema formally known as Atopic Dermatitis is a chronic inflammatory skin condition characterised by a compromised skin barrier, immune dysregulation, and heightened sensitivity to environmental and dietary triggers. It is not simply dry skin. It is not a hygiene problem. And it is not a skin condition that happens in isolation. Eczema is the skin's visible expression of a systemic immune and gut dysfunction that involves the skin barrier, the gut microbiome, the immune system, and the nervous system simultaneously. The itch-scratch cycle that characterises eczema is real and debilitating but the skin is not where the condition originates. It is where it expresses itself.

Eczema, asthma, and allergic rhinitis like hay fever form what is known as the atopic triad. They share the same underlying immune mechanism which is Th2 immune pathway overactivation and frequently co-occur in what clinicians call the atopic march. Eczema typically presents first in infancy, followed by food allergies, then asthma, then hay fever as the immune dysregulation progressively broadens its reach. This progression is not inevitable. It reflects an immune system operating in a terrain that has never been addressed at its root and the earlier that terrain is corrected the more of the atopic march can be prevented.

‍

People with eczema frequently have genetic variants in the filaggrin gene, a protein essential for maintaining the skin barrier's structural integrity. When filaggrin function is impaired the skin barrier becomes leaky allowing allergens, irritants, and microbes to penetrate and trigger immune activation. This same barrier dysfunction allows water to escape driving the characteristic dryness. But genetics are not destiny like filaggrin expression and skin barrier function are significantly influenced by nutrient status, gut health, and inflammatory burden. Addressing these modifiable factors meaningfully improves barrier function even in people with underlying genetic variants.

‍

Eczema prevalence in India is rising particularly in urban populations. Rapidly changing dietary patterns reducing microbiome diversity, widespread antibiotic use disrupting the gut-skin axis in early life, high rates of gut dysbiosis and intestinal permeability, widespread vitamin D deficiency impairing immune regulation, increasing environmental pollution amplifying skin and immune reactivity, and a medical system focused on topical management rather than systemic investigation all contribute to a growing eczema burden that is increasingly treatment resistant.

‍

Eczema is treated as a skin condition requiring barrier repair and immune suppression. What it actually reflects is a gut-immune-skin axis that has broken down. The gut microbiome directly regulates the Th1 and Th2 immune balance, and dysbiosis drives Th2 overactivation which is the primary immune mechanism in eczema. Intestinal permeability allows food and environmental antigens into the bloodstream sustaining the immune activation that drives skin inflammation. Address the gut and the immune terrain and the skin very often follows in a way that topical treatment alone never achieves.

‍